Wednesday, March 15, 2023 9:39:13 PM
The whole system is designed
To make one sick
So that they can sell the remedy
To what it caused
To make one sick
So that they can sell the remedy
To what it caused
Recent PFE News
- Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results • Business Wire • 05/20/2026 09:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:39:33 PM
- European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors • Business Wire • 05/13/2026 10:45:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 09:05:04 PM
- Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- The Next Generation of the GLP-1 Revolution Is Already Underway • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- The Next Generation of the GLP-1 Revolution Is Already Underway • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/05/2026 08:42:09 PM
- Pfizer tops Q1 expectations on growth from newer products • IH Market News • 05/05/2026 03:05:10 PM
- Wall Street Set for Rebound as Oil Prices Retreat Sharply: Dow Jones, S&P, Nasdaq, Futures • IH Market News • 05/05/2026 01:19:45 PM
- Wall Street Poised for Gains as Oil Prices Retreat: Dow Jones, S&P, Nasdaq, Futures • UK Market News • 05/05/2026 01:19:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 11:01:20 AM
- Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance • Business Wire • 05/05/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:20:12 PM
- Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma • Business Wire • 04/29/2026 10:45:00 AM
- Pfizer Reaches Three Settlement Agreements for VYNDAMAX • Business Wire • 04/28/2026 02:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:39:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:54 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/27/2026 10:23:31 PM


